Pulse Biosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PLSE and other ETFs, options, and stocks.

About PLSE

Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments using a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. 

CEO
Paul A. LaViolette
CEOPaul A. LaViolette
Employees
75
Employees75
Headquarters
Miami, Florida
HeadquartersMiami, Florida
Founded
2014
Founded2014
Employees
75
Employees75

PLSE Key Statistics

Market cap
1.60B
Market cap1.60B
Price-Earnings ratio
-20.61
Price-Earnings ratio-20.61
Dividend yield
Dividend yield
Average volume
728.93K
Average volume728.93K
High today
$24.87
High today$24.87
Low today
$22.98
Low today$22.98
Open price
$23.52
Open price$23.52
Volume
197.91K
Volume197.91K
52 Week high
$26.30
52 Week high$26.30
52 Week low
$12.56
52 Week low$12.56

Stock Snapshot

With a market cap of 1.6B, Pulse Biosciences(PLSE) trades at $23.58. The stock has a price-to-earnings ratio of -20.61.

On 2026-02-13, Pulse Biosciences(PLSE) stock traded between a low of $22.98 and a high of $24.87. Shares are currently priced at $23.58, which is +2.6% above the low and -5.2% below the high.

Pulse Biosciences(PLSE) shares are trading with a volume of 197.91K, against a daily average of 728.93K.

In the last year, Pulse Biosciences(PLSE) shares hit a 52-week high of $26.30 and a 52-week low of $12.56.

In the last year, Pulse Biosciences(PLSE) shares hit a 52-week high of $26.30 and a 52-week low of $12.56.

PLSE News

Simply Wall St 3d
Pulse Biosciences Is Up 70.4% After Strong First-in-Human nPulse AF Data Release – Has The Bull Case Changed?

In early February 2026, Pulse Biosciences reported late-breaking first-in-human data for its nPulse Cardiac Catheter, showing high atrial fibrillation treatment...

Pulse Biosciences Is Up 70.4% After Strong First-in-Human nPulse AF Data Release – Has The Bull Case Changed?

People also own

Based on the portfolios of people who own PLSE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.